Open AccessThe role of clinical diagnostic criteria for anti-N-methyl-D-aspartate receptor encephalitis in children: A case report
Author(s) -
Irawan Mangunatmadja,
Ricca Fauziyah,
Achmad Rafli
Publication year - 2022
Publication title -
paediatrica indonesiana
Language(s) - English
Resource type - Journals
eISSN - 2338-476X
pISSN - 0030-9311
DOI - 10.14238/pi62.1.2022.66-71
Subject(s) - encephalitis , medicine , autoimmune encephalitis , encephalopathy , pediatrics , incidence (geometry) , immunology , psychiatry , virus , physics , optics
Encephalitis is a neurological disorder that develops rapidly into a progressive encephalopathy caused by inflammatory processes in the brain. The incidence of encephalitis in developed countries is 5-10 per 100,000 per year. Encephalitis can affect all ages and cause long-term effects on patients, their families, and society.1-3 Autoimmune encephalitis, including anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis, is increasingly recognized as a cause of encephalitis in children and has a considerable mortality rate of 5-7%.4 Physicians should suspect anti-NMDAR encephalitis in patients with prominent neuropsychiatric symptoms and movement disorder.1-3 We report here a case of anti-NMDAR encephalitis and discuss the role of clinical criteria in diagnosing anti-NMDAR encephalitis in children.